维普中文期刊产品整合服务
12篇 您的检索式:作者名="MICHELACCI F"
    题名 作者 年代 出处 被引量
1Clinical im- pact of the methotrexate resistance - associated genes C - MYC and dihydrofolate reductase (DHFR) in high - grade osteosarcoma 显示文摘SCIONTI I MICHELACCI F PASELLO M 2008Ann Onco[2008,19,8:1
2Clinical im- pact of the methotrexate resistance-associated genes C-MYC and dihydro folate reductase(DHFR) in high-grade osteosarcoma显示文摘Scionti F Michelacci M Pasello C M 2008Annals of Oncology2008,19,8:1
3Characterization of glycosaminoglycans in tubular epithelial cells: calcium oxalate and oxalate ions effects 显示文摘Borges F T Michelacci Y M Aguiar J A 2005Kid Internation2005,68,4:1
4Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteo- sarcoma显示文摘Scionti I Michelacci F Pasello M 2008Ann Oncol2008,19,8:1
5Clinicalimpact of the methotrexate resistance-associatedgenes C-MYC and dihydrofolate reductase (DHFR)in high-grade osteosarcoma显示文摘Scionti I Michelacci F Pasello M 2008Ann Oncol2008,19,8:1
6Clinical impact of the methotrexatc resistance associated genes C-MYC and dihydrofolate reductase(DHFR) in high-grade osteosarcoma 显示文摘Scionti I Michelacci F Pasello M 2008Annals of Oncology2008,19,8:1
7Mechanisms of gene amplification and evidence of eoamplifieation in drug-resistant human osteosarcoma cell lines显示文摘Hattinger CM Stoico G Michelacci F 2009Genes Chromosomes Cancer2009,48,4:1
8Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma显示文摘Scionti I Michelacci F 2008Ann Oncol2008,8,:1
9Clinical impact of the methotrexate resistance associated genes C-MYC and dihydrofolate reductase(DHFR) in high-grade osteosarcoma显示文摘Scionti I Michelacci F Pasello M 2008Ann Oncol2008,19,:1
10Clincal impact of the methotrexate resistance-associated genes CMYC and dihydrofolate reductase(DHFR)in highgrade osteosarcoma显示文摘Scionti I Michelacci F Pasello M 2008Annals of Oncology2008,19,:1
11Development,characterizatian and in vivo evaluation of benzocalne-loaded liposomes显示文摘MURA P MAESTRELLI F MICHELACCI I 2007Eur J Pharm Biopharm2007,67,:1
12Chondrogenic potential of mesenchymal stem cells from horses using a magnetic 3D cell culture system显示文摘BACKGROUND Mesenchymal stem cells(MSCs)represent a promising therapy for the treatment of equine joint diseases,studied due to their possible immunomodulatory characteristics and regenerative capacity.However,the source of most suitable MSCs for producing cartilage for regenerative processes in conjunction with biomaterials for an enhanced function is yet to be established.AIM To compare the chondrogenicity of MSCs derived from synovial fluid,bone marrow,and adipose tissue of horses,using the aggrecan synthesis.METHODS MSCs from ten horses were cultured,phenotypic characterization was done with antibodies CD90,CD44 and CD34 and were differentiated into chondrocytes.The 3D cell culture system in which biocompatible nanoparticles consisting of gold,iron oxide,and poly-L-lysine were added to the cells,and they were forced by magnets to form one microspheroid.The microspheroids were exposed to a commercial culture medium for 4 d,7 d,14 d,and 21 d.Proteoglycan extraction was performed,and aggrecan was quantified by enzyme-linked immunosorbent assay.Keratan sulfate and aggrecan in the microspheroids were identified and localized by immunofluorescence.RESULTS All cultured cells showed fibroblast-like appearance,the ability to adhere to the plastic surface,and were positive for CD44 and CD90,thus confirming the characteristics and morphology of MSCs.The soluble protein concentrations were higher in the microspheroids derived from adipose tissue.The aggrecan concentration and the ratio of aggrecan to soluble proteins were higher in microspheroids derived from synovial fluid than in those derived from bone marrow,thereby showing chondrogenic superiority.Microspheroids from all sources expressed aggrecan and keratan sulfate when observed using confocal immunofluorescence microscopy.All sources of MSCs can synthesize aggrecan,however,MSCs from synovial fluid and adipose tissue have demonstrated better biocompatibility in a 3D environment,thus suggesting chondrogenic superiority.CONCLUSION All sources of MSCs produce hyaline cartilage;however,the use of synovial liquid or adipose tissue should be recommended when it is intended for use with biomaterials or scaffolds.Joice Fülber Fernanda R Agreste Sarah R T Seidel Eric D P Sotelo Ângela P Barbosa Yara M Michelacci Raquel Y A Baccarin 2021World Journal of Stem Cells2021,13,6:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费